Mr Andrew Davies

  • Senior Health Economist (Health Economics & Health Technology Assessment)

Publications

List by: Type | Date

Jump to: 2020 | 2019
Number of items: 3.

2020

Xin, Yiqiao ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, Briggs, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, McCombie, Louise, Messow, C. Martina ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2020) Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia, 63, pp. 2112-2122. (doi: 10.1007/s00125-020-05224-2) (PMID:32776237) (PMCID:PMC7476973)

2019

Xin, Y. ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, A., McCombie, L., Briggs, A. ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-M. ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, E. ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, W.S., Taylor, R. and Lean, M.E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2019) Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial. Diabetic Medicine, 36(8), pp. 1003-1012. (doi: 10.1111/dme.13981) (PMID:31026353)

Xin, Yiqiao ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, McCombie, Louise, Briggs, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-Martina ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2019) Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet Diabetes and Endocrinology, 7(3), pp. 169-172. (doi: 10.1016/S2213-8587(18)30346-2) (PMID:30581081)

This list was generated on Mon Jun 16 01:15:18 2025 BST.
Jump to: Articles
Number of items: 3.

Articles

Xin, Yiqiao ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, Briggs, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, McCombie, Louise, Messow, C. Martina ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2020) Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia, 63, pp. 2112-2122. (doi: 10.1007/s00125-020-05224-2) (PMID:32776237) (PMCID:PMC7476973)

Xin, Y. ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, A., McCombie, L., Briggs, A. ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-M. ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, E. ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, W.S., Taylor, R. and Lean, M.E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2019) Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial. Diabetic Medicine, 36(8), pp. 1003-1012. (doi: 10.1111/dme.13981) (PMID:31026353)

Xin, Yiqiao ORCID logoORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, McCombie, Louise, Briggs, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-Martina ORCID logoORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID logoORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID logoORCID: https://orcid.org/0000-0003-2216-0083 (2019) Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet Diabetes and Endocrinology, 7(3), pp. 169-172. (doi: 10.1016/S2213-8587(18)30346-2) (PMID:30581081)

This list was generated on Mon Jun 16 01:15:18 2025 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Economic Evaluation of the Diabetes Remission Clinical Trial DiRECT
    Diabetes UK
    2018 - 2019
     
  • Reversal of T2DM to normal glucose tolerance using non-surgical weight management with low-energy liquid- diet and long-term maintenance, within routine NHS care: study extension
    Diabetes UK
    2017 - 2021